← FDA Drug Approvals (Drugs@FDA)
NOREPINEPHRINE BITARTRATE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: CAPLIN · Approved 2023-09-15
Drug application
- FDA Application #
ANDA217575- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- NOREPINEPHRINE BITARTRATE
- Generic name
- NOREPINEPHRINE BITARTRATE
- Active ingredients
- NOREPINEPHRINE BITARTRATE
- Dosage form
- INJECTABLE
- Route
- INJECTION
- Marketing status
- Prescription
- Sponsor
- CAPLIN
- Manufacturer
- NorthStar Rx LLC
- First approval
- 2023-09-15
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown